498 related articles for article (PubMed ID: 32509600)
21. Natural killer cell epigenetic reprogramming in tumors and potential for cancer immunotherapy.
Hojjatipour T; Maali A; Azad M
Epigenomics; 2023 Feb; 15(4):249-266. PubMed ID: 37125432
[TBL] [Abstract][Full Text] [Related]
22. NK cell-based cancer immunotherapy: from basic biology to clinical application.
Li Y; Yin J; Li T; Huang S; Yan H; Leavenworth J; Wang X
Sci China Life Sci; 2015 Dec; 58(12):1233-45. PubMed ID: 26588912
[TBL] [Abstract][Full Text] [Related]
23. Natural killer cells in hepatitis C virus infection: from innate immunity to adaptive immunity.
Takehara T; Hayashi N
Clin Gastroenterol Hepatol; 2005 Oct; 3(10 Suppl 2):S78-81. PubMed ID: 16234066
[TBL] [Abstract][Full Text] [Related]
24. Innate Lymphoid Cells in Protection, Pathology, and Adaptive Immunity During Apicomplexan Infection.
Ivanova DL; Denton SL; Fettel KD; Sondgeroth KS; Munoz Gutierrez J; Bangoura B; Dunay IR; Gigley JP
Front Immunol; 2019; 10():196. PubMed ID: 30873151
[TBL] [Abstract][Full Text] [Related]
25. Natural Killer Cells in Liver Disease and Hepatocellular Carcinoma and the NK Cell-Based Immunotherapy.
Liu P; Chen L; Zhang H
J Immunol Res; 2018; 2018():1206737. PubMed ID: 30255103
[TBL] [Abstract][Full Text] [Related]
26. Natural killer cell-based immunotherapy: From transplantation toward targeting cancer stem cells.
Dianat-Moghadam H; Rokni M; Marofi F; Panahi Y; Yousefi M
J Cell Physiol; 2018 Jan; 234(1):259-273. PubMed ID: 30144312
[TBL] [Abstract][Full Text] [Related]
27. Redefining Memory: Building the Case for Adaptive NK Cells.
Paust S; Blish CA; Reeves RK
J Virol; 2017 Oct; 91(20):. PubMed ID: 28794018
[TBL] [Abstract][Full Text] [Related]
28. Targeting Innate Immunity to Enhance the Efficacy of Radiation Therapy.
Dar TB; Henson RM; Shiao SL
Front Immunol; 2018; 9():3077. PubMed ID: 30692991
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological targeting of natural killer cells for cancer immunotherapy.
Miyazato K; Hayakawa Y
Cancer Sci; 2020 Jun; 111(6):1869-1875. PubMed ID: 32301190
[TBL] [Abstract][Full Text] [Related]
30. Targeting natural killer cells in cancer immunotherapy.
Guillerey C; Huntington ND; Smyth MJ
Nat Immunol; 2016 Aug; 17(9):1025-36. PubMed ID: 27540992
[TBL] [Abstract][Full Text] [Related]
31. Localization Matters: Epigenetic Regulation of Natural Killer Cells in Different Tissue Microenvironments.
Wiedemann GM
Front Immunol; 2022; 13():913054. PubMed ID: 35707540
[TBL] [Abstract][Full Text] [Related]
32. Unleashing Natural Killer Cells in the Tumor Microenvironment-The Next Generation of Immunotherapy?
Ben-Shmuel A; Biber G; Barda-Saad M
Front Immunol; 2020; 11():275. PubMed ID: 32153582
[TBL] [Abstract][Full Text] [Related]
33. The natural killer cell: a further innate mediator of gouty inflammation?
Empson VG; McQueen FM; Dalbeth N
Immunol Cell Biol; 2010 Jan; 88(1):24-31. PubMed ID: 19935769
[TBL] [Abstract][Full Text] [Related]
34. Tissue-resident and memory properties of human T-cell and NK-cell subsets.
Lugli E; Hudspeth K; Roberto A; Mavilio D
Eur J Immunol; 2016 Aug; 46(8):1809-17. PubMed ID: 27431095
[TBL] [Abstract][Full Text] [Related]
35. The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy.
Fraker C; Bayer AL
Curr Diab Rep; 2016 Nov; 16(11):109. PubMed ID: 27664042
[TBL] [Abstract][Full Text] [Related]
36. The role of natural killer cell in gastrointestinal cancer: killer or helper.
Wang F; Lau JKC; Yu J
Oncogene; 2021 Jan; 40(4):717-730. PubMed ID: 33262461
[TBL] [Abstract][Full Text] [Related]
37. Natural killer cells and anti-tumor immunity.
Nicholson SE; Keating N; Belz GT
Mol Immunol; 2019 Jun; 110():40-47. PubMed ID: 29233542
[TBL] [Abstract][Full Text] [Related]
38. Effector and cytolytic function of natural killer cells in anticancer immunity.
Karmakar S; Mishra A; Pal P; Lal G
J Leukoc Biol; 2024 Jan; 115(2):235-252. PubMed ID: 37818891
[TBL] [Abstract][Full Text] [Related]
39. Role of natural killer and B cell interaction in inducing pathogen specific immune responses.
Tandel N; Negi S; Dalai SK; Tyagi RK
Int Rev Immunol; 2023; 42(4):304-322. PubMed ID: 36731424
[TBL] [Abstract][Full Text] [Related]
40. [Natural killer (NK) cell and immunotherapy].
Iino T; Takaishi S
Nihon Rinsho; 2017 Feb; 75(2):306-311. PubMed ID: 30562869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
